Clinical Trial

SWITCH: Apixaban vs Vitamin K in HM3

Name: SWITCH: Apixaban vs Vitamin K in HM3 — clinical trial record (NCT07471139)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study is being done to learn the safety and efficacy of a new anticoagulant therapy with apixaban as compared to warfarin to prevent thrombotic events while protecting from bleeding complications in patients with advanced heart failure who are chronically supported by a HeartMate 3 Left Ventricular Assist Device for 3 months.

Trial Details

NCT Number	NCT07471139
Lead Sponsor	Columbia University
Conditions	LVAD (Left Ventricular Assist Device) Thrombosis, Heart Failure, Bleeding, Thrombosis; Artery, Stroke, Heart Transplant
Enrollment	460 participants
Start Date	2026-06
Primary Completion	2029-06 (estimated)
Study Completion	2029-06 (estimated)
Updated on ClinicalTrials.gov	2026-03-13